INACTIVATION: IMMUNE PROPHYLAXIS AGAINST HIV-1 TRANSMISSION Release Date: September 15, 1998 PA NUMBER: PA 98-038 P.T. National Institute of Allergy and Infectious Diseases The National Institute of Allergy and Infectious Diseases (NIAID) is inactivating program announcement PA 98-038, Immune Prophylaxis Against HIV-1 Transmission, which appeared in the NIH Guide, March 6, 1998. NIAID will not give special consideration for funding to applications in response to this PA received after January 2, 1999. NIAID regularly reviews its portfolio of active program announcements. When the objectives of PAs have been attained, NIAID announces inactivation of those PAs. NIAID supports highly scientifically meritorious applications in all areas of research within its mission. PA inactivation simply means that special consideration for funding beyond normal paylines will NO LONGER be given to applications on the research topics identified in the inactivated PAs. However, such applications will be accepted, reviewed, and considered for funding according the usual procedures. At any time, potential applicants can obtain a current listing of active NIAID PAs on the NIAID WWW site at URL: http://www.niaid.nih.gov/ncn/pa-table.htm INQUIRIES For questions or further information, contact: Office of the Director Division of Extramural Activities National Institute of Allergy and Infectious Diseases Solar Building, Room 3C20 Bethesda, MD 20892-7610 Telephone: (301) 496-7291 FAX: (301) 402-0369 Email: ac20a@nih.gov
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |